You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 26, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Aaron W P Maxwell1, Humberto G Mendoza2, Matthew J Sellitti3
1Department of Diagnostic Imaging, The Warren Alpert Medical School, Brown University, Providence, RI, USA.
Optimizing particle density in radioembolization improves treatment outcomes. Tailoring particle delivery based on tumor vascularity enhances local progression-free survival and overall survival, outperforming conventional dosimetry.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: